Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $23.8000 (-0.83%) ($23.1100 - $24.0000) on Mon. Oct. 30, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.53% (three month average) | RSI | 48 | Latest Price | $23.8000(-0.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.9% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) SKYY(8%) TBT(8%) ARKK(7%) EWI(7%) | Factors Impacting CAPR price | CAPR will decline at least -5.765% in a week (0% probabilities). TLT(-8%) GLD(-8%) GDX(-8%) SLV(-6%) SIL(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.765% (StdDev 11.53%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
1 - 5 Day Possible Target | $-0.75(-103.15%) | Resistance Level | $25.31 | 5 Day Moving Average | $23.4(1.71%) | 10 Day Moving Average | $23.6(0.85%) | 20 Day Moving Average | $25.31(-5.97%) | To recent high | -31% | To recent low | 145.4% | Market Cap | $469m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |